AVEO: LG Chem to start Phase 3 for head, neck cancer drug in US
South Korea's LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its head and n
Read full article »
AVEO is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Read more